Unit 6 - Cholesterol Metabolism I; Synthesis of Cholesterol, Bile Salts, and Acids Flashcards
overall cholesterol structure
4 planar hydrocarbon rings (A-D) of steroid nucleus
- has 8 carbon hydrocarbon attached to C17 of D-ring
- hydroxyl group attached to C3 of A ring
- DB between C5/6 of B right
- most cholesterol in plasma is esterified to FA at C3, and this cholesteryl ester is even more hydrophobic than cholesterol
how much animal VS plant sterols are absorbed from diet?
40% of cholesterol
5% of phytosterols
what is beta-sitosterol?
plant sterol
what happens to plant sterols and excess cholesterol upon entering enterocytes?
actively transported back into intestinal lumen by 2 members of ATP binding cassette (ABC) family of transporters
what is sitosterolemia?
autosomal recessive condition where sterol transporters ABCG5 and ABCG8 are defective
-accumulated beta-sitosterol and cholesterol in enterocytes enter blood stream to cause increased cardiovascular morbidity
where is cholesterol made? where do the carbons come from? reducing equivalents? energy?
virtually all cells except RBCs in humans
- majority in liver, intestines, adrenal cortex, and reproductive tissues
- like FAS, all carbons from ACoA, while NADPH is reducing equivalents
- E from hydrolysis of thioester bond of ACoA and terminal Pi of ATP
- this happens on cytoplasmic surface of SER, and needs ER membrane and cytosolic enzymes
does the HMG-CoA synthase for cholesterol work in the cytosol or the mitochondria?
the cytosol
what is the key regulatory step for cholesterol synthesis?
HMG CoA reductase (integrated in SER facing cytoplasm)
- converts HMG CoA to mevalonate
- needs 2 NADPH, and CoA is released so irreversible
- inhibited by cholesterol
what is isopentenyl pyrophosphate (IPP)
made in 8-step pathway for mevalonate to cholesterol
-precursor for isoprenoids (dolichol, CoQ, vit K, cholesterol)
what are the 8 steps from mevalonate to cholesterol?
- phosphorylation via 2 kinases (takes 2 ATP) = 6C
- decarboxylation (takes 1 ATP, releases CO2) = 5C
- isomerization = 5C
- transferase (adds 1 IPP from 2) = 10C
- transferase (adds 1 IPP from 2) = 15C
- squalene synthase (adds 1 FPP from 5, needs 1 NADPH, releases 2 PPi and NADP+) = 30C
- squalene monoxygenase (needs NADPH + O2, releases H2O and NADP) = 30C sterol
- multistep reaction in ER = 27C cholesterol
what is smith-lemli-opitz syndrome?
an autosomal recessive disorder of cholesterol biosynthesis
- caused by partial deficiency in 7-dehydrocholesterol-7-reductase that reduces DB in 7-DHC to convert to cholesterol
- one of the several multisystem embryonic malformation syndromes associated with impaired cholesterol synthesis
how is HMG-CoA reductase regulated? proteins involved, areas involved, difference if low/high cholesterol, etc.
under control of transcription factor SREBP-2 (sterol regulatory element binding PRO 2) that binds cis acting SRE (sterol regulatory element)
- inactive SREBP-2 is integral ER membrane PRO that associates with ER PRO SCAP (SREBP cleavage activating PRO)
- when cholesterol levels are low, SREBP-2-SCAP complex moves to Golgi to cleave SREBP to soluble fragment (activated SREBP transcription factors)
- -SREBP transcription factor enters nucleus, binds SRE, and stimulates HMG CoA reductase mRNA and enzyme expression
- when cholesterol levels are high, it binds to SCAP, which binds to more ER PRO insigs (insulin induced gene products) that anchor SREBP-2-SCAP to ER membrane, so can’t go to Golgi and synthesis decreases
how is HMG-CoA reductase degraded?
when cholesterol levels are high, they bind to sterol-sensing domain of HMG-CoA reductase
-causes binding of reductase to insigs (as if SCAP was activated), and triggers ubiquitination and proteosomal degradation of enzyme, leading to reduced cholesterol biosynthesis
how does phosphorylation affect HMG-CoA reductase?
phosphorylated = inactive (AMP-activated protein kinase; if AMP is high and ATP is low)
dephosphorylated = active (phosphoprotein phosphatase; if AMP is low and ATP is high)
how do hormones affect HMG-CoA reductase?
insulin and thyroxine upregulate expression
glucagon and glucocorticoids downregulate expression